The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Beneficial effects of treatment of early subclinical rejection: a randomized study.
Abstract
The prevalence of subclinical rejection, by the Banff criteria, is approximately 30% in the first 3 mo in renal transplant recipients. A randomized study was performed to determine whether the treatment of subclinical rejection with corticosteroids was associated with improved outcomes in these patients. Seventy-two patients, stratified by donor source, were randomized to biopsies at 1, 2, 3, 6, and 12 mo (Biopsy group), or to 6- and 12-mo biopsies only (Control group). Patients were analyzed by "intent to treat" and were followed for a minimum of 2 yr. Patients in the Biopsy arm of the study had a significant decrease in early (months 2 and 3) and late (months 7 to 12) acute rejection episodes, a reduced chronic tubulointerstitial score at 6 mo, and a lower serum creatinine at 24 mo than did patients in the Control arm. There was a trend toward an increase in infectious morbidity, but no increase in mortality, in the patients randomized to the Biopsy group. The results of this study suggest that early protocol biopsies and the treatment of subclinical rejection with corticosteroids may lead to better histologic and functional outcomes in renal transplant recipients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
DELAYED GRAFT FUNCTION: RISK FACTORS AND IMPLICATIONS FOR RENAL ALLOGRAFT SURVIVAL1
Ojo, A. O., Wolfe, R. A., Held, P. J., Port, F. K., & Schmouder, R. L. (1997) · Transplantation · doi:10.1097/00007890-199704150-00011 · Cited by 989
EARLY VERSUS LATE ACUTE RENAL ALLOGRAFT REJECTION: IMPACT ON CHRONIC REJECTION
BASADONNA, G. P., MATAS, A. J., GILLINGHAM, K. J., PAYNE, W. D., DUNN, D. L., SUTHERLAND, D. E. R., GORES, P. F., GRUESSNER, R. W. G., & NAJARIAN, J. S. (1993) · Transplantation · doi:10.1097/00007890-199305000-00007 · Cited by 353
Paul, L. C. (1995) · Kidney International · doi:10.1038/ki.1995.211 · Cited by 243
Halloran, P. F., Homik, J., Goes, N., Lui, S. L., Urmson, J., Ramassar, V., & Cockfield, S. M. (1997) · Transplantation Proceedings · doi:10.1016/s0041-1345(96)00015-2 · Cited by 220
Nickerson, P., Jeffery, J., Gough, J., McKenna, R., Grimm, P., Cheang, M., & Rush, D. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v93482 · Cited by 163
Self-citationLONG-TERM RENAL ALLOGRAFT SURVIVAL
Leggat, J. E., OJO, A. O., Leichtman, A. B., Port, F. K., Wolfe, R. A., Turenne, M. N., & Held, P. J. (1997) · Transplantation · doi:10.1097/00007890-199705150-00013 · Cited by 103
Design of trials of methods to reduce late renal allograft loss: the price of success.
Hunsicker, L. G., & Bennett, L. E. (1995) · PubMed · Cited by 45
Cited by
The Banff 97 working classification of renal allograft pathology
Racusen, L. C., Solez, K., Colvin, R. B., Bonsib, S. M., Castro, M. C., Cavallo, T., Croker, B. P., Demetris, A. J., Drachenberg, C. B., Fogo, A. B., et al. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00299.x · Cited by 3,033
Self-citationSpecial Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Eckardt, K.-U., Kasiske, B. L., & Zeier, M. G. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02834.x · Cited by 1,499
MacDonald, A. S. (2001) · Transplantation · doi:10.1097/00007890-200101270-00019 · Cited by 621
Li, B., Hartono, C., Ding, R., Sharma, V. K., Ramaswamy, R., Qian, B., Serur, D., Mouradian, J., Schwartz, J. E., & Suthanthiran, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441301 · Cited by 599
Chronic Allograft Nephropathy: Current Concepts and Future Directions
Nankivell, B. J., & Chapman, J. R. (2006) · Transplantation · doi:10.1097/01.tp.0000190423.82154.01 · Cited by 338
Metadata
- Authors
- Rush, D., Nickerson, P., Gough, J., McKenna, R., Grimm, P., Cheang, M., Trpkov, K., Solez, K., & Jeffery, J.
- Venue
- Journal of the American Society of Nephrology
- Published
- 1998-11
- Volume
- 9
- Issue
- 11
- Pages
- 2129-2134
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2134869152
- Cited by
- 472
- References
- 9
- FWCI
- 16.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Beneficial effects of treatment of early subclinical rejection: a randomized study. https://app.cochat.ai/papers/10.1681/asn.v9112129
- The paper
- Rush, D., Nickerson, P., Gough, J., McKenna, R., Grimm, P., Cheang, M., Trpkov, K., Solez, K., & Jeffery, J. (1998). Beneficial effects of treatment of early subclinical rejection: a randomized study. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.v9112129
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
